News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily5d agobullish
Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.Investor's Business Daily5d agobullish
Amgen, Up 42% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.24/7 Wall St.6d agobullish
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?Proactive46d agoneutral
Amgen price target raised by Jefferies to $410 after positive Sjögren's dataThe Wall Street Journal57d agoneutral
Heart Disease, a Historic Strength for Big Pharma, Becomes a WeaknessThe Wall Street Journal61d agoneutral
Amgen Stock Poised for Worst Day in More Than Two Decades